Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.

Liang Liu, Shuping Huo, Jianghui Liu, Qiaomin Li, Jing Wang

Journal: Discovery medicine 2022;31(164):141-146

PMID: 35188888

Abstract

A large number of studies on the metabolism of immune cells in anti-tumor response have been carried out in recent years. It is proved that metabolic reprogramming can determine the differentiation and functions of immune cells. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immunosuppressive cells in the tumor microenvironment (TME). They can significantly inhibit the anti-tumor response of T cells and play an important role in promoting tumor growth, metastasis, and invasion. This review summarizes the energy metabolic pathways of MDSCs in the TME, such as fatty acid oxidation (FAO), glycolysis, and amino acids (AAs) metabolism, and highlights the importance of metabolic reprogramming of MDSCs for its immunosuppressive functions.

Address: Hebei Provincial Cancer Institute, Shijiazhuang, Hebei 050011, China.; Department of Anesthesiology, the third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei 050021, China.; Corresponding author.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.